Specific immune defense against cariogenic mutans streptococci is provided
largely by salivary secretory IgA antibodies, which are generated by the co
mmon mucosal immune system. This system is functional in newborn infants, w
ho develop salivary IgA antibodies as they become colonized by oral microor
ganisms. The mechanisms of action of salivary IgA antibodies include interf
erence with sucrose-independent and sucrose-dependent attachment of mutans
streptococci to tooth surfaces, as well as possible inhibition of metabolic
activities. The goal of protecting infants against colonization by mutans
streptococci might be accomplished by applying new strategies of mucosal im
munization that would induce salivary IgA antibodies without the complicati
ons of parenteral immunization. Strategies of mucosal immunization against
mutans streptococci currently under development include the use of surface
adhesins and glucosyltransferase as key antigens, which are being incorpora
ted into novel mucosal vaccine delivery systems and adjuvants. The oral app
lication of preformed, genetically engineered antibodies to mutans streptoc
occal antigens also offers new prospects for passive immunization against d
ental caries.